Early atherosclerosis and IgG2 to bacteria are associated with FcγRIIa genotype in non-smokers

European Journal of Clinical Investigation

Volumn 39, Issue 6, 2009, Pages 517-526

  Sampi M ^a   Ukkola, O ^a   Paivansalo M ^a   Kesaniemi Y A ^a   Horkko S ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Atherosclerosis; Fc RIIa; IgG2; Polymorphism; Population based; Streptococcus pneumoniae

Indexed keywords

ARGININE; FC RECEPTOR IIA; HISTIDINE; IMMUNOGLOBULIN G2; OXIDIZED LOW DENSITY LIPOPROTEIN; FC RECEPTOR; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIAE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PNEUMOCOCCAL INFECTION;

ATHEROSCLEROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 65549108406     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02138.x     Document Type: Article

References (49)

1. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell 2001 104 : 503 16. (Pubitemid 32201946)
2. Binder CJ, Hörkkö S, Dewan A, Chang M, Kieu EP, Goodyear CS et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003 9 : 736 43. (Pubitemid 36749223)
3. Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 2007 48 : 425 33. (Pubitemid 46220609)
4. Karvonen J, Päivänsalo M, Kesäniemi YA, Hörkkö S. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 2003 108 : 2107 12. (Pubitemid 37337587)
5. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992 339 : 883 7.
6. Su J, Georgiades A, Wu R, Thulin T, de Faire U, Frostegrd J. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 2006 188 : 160 6. (Pubitemid 44160704)
7. Sjöberg BG, Su J, Dahlbom I, Grönlund H, Wikström M, Hedblad B et al. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Atherosclerosis 2009 203 : 528 32.
8. Frostegrd J, Tao W, Georgiades A, Rstam L, Lindblad U, Lindeberg S. Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea. Nutr Metab (Lond) 2007 4 : 7. (Pubitemid 46626118)
9. van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991 49 : 511 24.
10. van der Pol W, van de Winkel JG. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998 48 : 222 32.
11. Rodriguez ME, van der Pol WL, Sanders LA, van de Winkel JG. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J Infect Dis 1999 179 : 423 33. (Pubitemid 29086645)
12. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 1991 147 : 1338 43.
13. Yuan FF, Wong M, Pererva N, Keating J, Davis AR, Bryant JA et al. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2003 81 : 192 5. (Pubitemid 36649265)
14. Wu R, Lefvert AK. Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol 1995 102 : 174 80.
15. Ratcliffe NR, Kennedy SM, Morganelli PM. Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions. Immunol Lett 2001 77 : 169 74. (Pubitemid 32532072)
16. Nagarajan S. Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion. Immunol Lett 2007 108 : 52 61.
17. Hart SP, Alexander KM, Dransfield I. Immune complexes bind preferentially to Fc gamma RIIA (CD32) on apoptotic neutrophils, leading to augmented phagocytosis by macrophages and release of proinflammatory cytokines. J Immunol 2004 172 : 1882 7. (Pubitemid 38116838)
18. Devaraj S, Du Clos TW, Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol 2005 25 : 1359 63. (Pubitemid 40923352)
19. Hernández-Vargas P, Ortiz-Muñoz G, López-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuán G et al. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 2006 99 : 1188 96.
20. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 1999 190 : 585 90. (Pubitemid 29395386)
21. Morganelli PM, Groveman DS, Pfeiffer JR. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL. Arterioscler Thromb Vasc Biol 1997 17 : 3248 54. (Pubitemid 28016085)
22. van der Meer IM, Witteman JCM, Hofman A, Kluft C, de Maat MPM. Genetic variation in Fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study. Thromb Haemost 2004 92 : 1273 6. (Pubitemid 39642536)
23. Mollaki V, Steeds RP, Samani NJ, Channer KS, Daly ME. The FcgammaRIIa His131Arg polymorphism and its association with myocardial infarction. J Thromb Haemost 2004 2 : 1014 5. (Pubitemid 40185754)
24. Gardemann A, Horstmann A, Santoso S. Fc gamma RIIa-R131H polymorphism: its impact on coronary heart disease in a German cohort. Thromb Haemost 2003 90 : 1218 20. (Pubitemid 38004448)
25. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996 28 : 1070 5. (Pubitemid 26415826)
26. Päivänsalo M, Rantala A, Kauma H, Lilja M, Reunanen A, Savolainen M et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound. J Hypertens 1996 14 : 1433 9. (Pubitemid 27007812)
27. Jiang XM, Arepally G, Poncz M, McKenzie SE. Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods 1996 199 : 55 9. (Pubitemid 26392327)
28. Lehrnbecher T, Foster CB, Zhu S, Leitman SF, Goldin LR, Huppi K et al. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 1999 94 : 4220 32.
29. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996 98 : 800 14. (Pubitemid 26349186)
30. Freigang S, Hörkkö S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde- modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 1998 18 : 1972 82. (Pubitemid 28565762)
31. Habeeb AF. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 1966 14 : 328 36.
32. Hörkkö S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 1999 103 : 117 28. (Pubitemid 29031170)
33. van der Pol W, Jansen MD, Sluiter WJ, van de Sluis B, Leppers-van de Straat FGJ, Kobayashi T et al. Evidence for non-random distribution of Fcgamma receptor genotype combinations. Immunogenetics 2003 55 : 240 6. (Pubitemid 36960517)
34. Joutsi L, Javela K, Partanen J, Kekomäki R. Genetic polymorphism H131R of Fcgamma receptor type IIA (FcgammaRIIA) in a healthy Finnish population and in patients with or without platelet-associated IgG. Eur J Haematol 1998 61 : 183 9. (Pubitemid 28439340)
35. Hörkkö S, Binder CJ, Shaw PX, Chang MK, Silverman G, Palinski W et al. Immunological responses to oxidized LDL. Free Radic Biol Med 2000 28 : 1771 9. (Pubitemid 30628664)
36. van Sorge NM, van der Pol W, van de Winkel JGJ. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003 61 : 189 202. (Pubitemid 36605541)
37. Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 2000 105 : 369 76. (Pubitemid 30094457)
38. Manolov DE, Röcker C, Hombach V, Nienhaus GU, Torzewski J. Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcgammaRIIa. Arterioscler Thromb Vasc Biol 2004 24 : 2372 7. (Pubitemid 39658044)
39. Parren PW, Warmerdam PA, Boeije LC, Arts J, Westerdaal NA, Vlug A et al. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992 90 : 1537 46.
40. Lopes-Virella MF, Virella G. The role of immune and inflammatory processes in the development of macrovascular disease in diabetes. Front Biosci 2003 8 : s750 68. (Pubitemid 39144358)
41. Pfeiffer JR, Howes PS, Waters MA, Hynes ML, Schnurr PP, Demidenko E et al. Levels of expression of Fcgamma receptor IIA (CD32) are decreased on peripheral blood monocytes in patients with severe atherosclerosis. Atherosclerosis 2001 155 : 211 8. (Pubitemid 32167142)
42. Paffen E, DeMaat MPM. C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 2006 71 : 30 9. (Pubitemid 43870060)
43. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM. Systemic effects of smoking. Chest 2007 131 : 1557 66. (Pubitemid 46762366)
44. de Ferranti SD, Rifai N. C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 2007 16 : 14 21. (Pubitemid 46049026)
45. Chang M, Binder CJ, Torzewski M, Witztum JL. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 2002 99 : 13043 8.
46. Quinn SM, Zhang JB, Gunsolley JC, Schenkein JG, Schenkein HA, Tew JG. Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients. Infect Immun 1996 64 : 2500 5. (Pubitemid 26226810)
47. Tani S, Dimayuga PC, Anazawa T, Chyu K, Li H, Shah PK et al. Aberrant antibody responses to oxidized LDL and increased intimal thickening in apoE-/- mice exposed to cigarette smoke. Atherosclerosis 2004 175 : 7 14. (Pubitemid 38746904)
48. Schenkein HA, Berry CR, Purkall D, Burmeister JA, Brooks CN, Tew JG. Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins. Infect Immun 2001 69 : 6612 7. (Pubitemid 32995415)
49. Frasch CE, Concepcion NF. Specificity of human antibodies reactive with pneumococcal C polysaccharide. Infect Immun 2000 68 : 2333 7. (Pubitemid 30164872)